SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001485003-15-000019
Filing Date
2015-11-06
Accepted
2015-11-06 16:12:23
Documents
4
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A q32015form10-q_a.htm 10-Q/A 42047
2 EXHIBIT 10.1 elevenleaseamendment.htm EX-10.1 27601
3 EXHIBIT 31.3 q32015form10-q_aexhibit313.htm EX-31.3 5944
4 EXHIBIT 31.4 q32015form10-q_aexhibit314.htm EX-31.4 5930
  Complete submission text file 0001485003-15-000019.txt   82546
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36296 | Film No.: 151210858
SIC: 2834 Pharmaceutical Preparations